PlainRecalls
FDA Drug Moderate Class II Terminated

Ranitidine Oral Solution, USP, 150 mg/10 mL, [10 mL x 30 Unit Dose Cups per case, NDC: 68094-204-62; 10 mL x 100 Unit Dose Cups per case, NDC: 68094-204-61; Unit Dose Cup NDC: 68094-204-59], Rx only, Precision Dose, Inc., South Beloit, IL 61080

Reported: March 18, 2020 Initiated: November 13, 2019 #D-1004-2020

Product Description

Ranitidine Oral Solution, USP, 150 mg/10 mL, [10 mL x 30 Unit Dose Cups per case, NDC: 68094-204-62; 10 mL x 100 Unit Dose Cups per case, NDC: 68094-204-61; Unit Dose Cup NDC: 68094-204-59], Rx only, Precision Dose, Inc., South Beloit, IL 61080

Reason for Recall

CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.

Details

Recalling Firm
Precision Dose Inc.
Units Affected
224,940 unit dose cups
Distribution
Nationwide USA
Location
South Beloit, IL

Frequently Asked Questions

What product was recalled?
Ranitidine Oral Solution, USP, 150 mg/10 mL, [10 mL x 30 Unit Dose Cups per case, NDC: 68094-204-62; 10 mL x 100 Unit Dose Cups per case, NDC: 68094-204-61; Unit Dose Cup NDC: 68094-204-59], Rx only, Precision Dose, Inc., South Beloit, IL 61080. Recalled by Precision Dose Inc.. Units affected: 224,940 unit dose cups.
Why was this product recalled?
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 18, 2020. Severity: Moderate. Recall number: D-1004-2020.